Stay updated with breaking news from Pacific Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell and Gene Therapy Supply Chain/Logistics Market...
Asia Pacific Cell & Gene Research: Novotech is Growing 50% Faster than ROW
In space, nobody can hear you scream, but they can on the ground when it involves figuring out what’s going on in space.
Several companies are involved in strategic alliances to boost their offerings in the space, that is projected to strengthen the market competition during...
Lion TCR Pte Ltd, clinical-stage biotech company specialized in the development and commercialization of its proprietary engineered T Cell Receptor (TCR) products against infectious disease and its associated cancers, has been recognized as the ‘Most Promising Cell & Gene Therapy Startup in Asia’ category at the Asia-Pacific Cell & Gene Therapy Excellence Awards (ACGTEA) 2022, organized by IMAPAC.